{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:03:57Z","timestamp":1775865837621,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03749-7","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T11:52:04Z","timestamp":1742385124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases at an Australian centre"],"prefix":"10.1186","volume":"23","author":[{"given":"Raymond","family":"Hayler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Domingos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Ashrafizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruwanthi","family":"Wijayawardana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winston","family":"Liauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"issue":"3","key":"3749_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, van Gestel YR, van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134(3):622\u20138.","journal-title":"Int J Cancer"},{"issue":"3","key":"3749_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/ijc.2910570307","volume":"57","author":"H Juhl","year":"1994","unstructured":"Juhl H, Stritzel M, Wroblewski A, Henne-Bruns D, Kremer B, Schmiegel W, et al. Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer. 1994;57(3):330\u20135.","journal-title":"Int J Cancer"},{"key":"3749_CR3","doi-asserted-by":"crossref","unstructured":"Gamboa AC, Winer JH. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer. Cancers (Basel). 2019;11(11).","DOI":"10.3390\/cancers11111662"},{"issue":"1","key":"3749_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1245\/s10434-019-07624-0","volume":"27","author":"L Ji","year":"2020","unstructured":"Ji L, Selleck MJ, Morgan JW, Xu J, Babcock BD, Shavlik D, et al. Gastric cancer peritoneal carcinomatosis risk score. Ann Surg Oncol. 2020;27(1):240\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"21","key":"3749_CR5","first-page":"4882","volume":"10","author":"A Rijken","year":"2021","unstructured":"Rijken A, Lurvink RJ, Luyer MDP, Nieuwenhuijzen GAP, van Erning FN, van Sandick JW, et al. The burden of peritoneal metastases from gastric cancer: A systematic review on the incidence. Risk Factors Survival. 2021;10(21):4882.","journal-title":"Risk Factors Survival"},{"key":"3749_CR6","doi-asserted-by":"crossref","unstructured":"Manzanedo I, Pereira F, P\u00e9rez-Viejo E, Serrano \u00c1. Gastric cancer with peritoneal metastases: current status and prospects for treatment. Cancers (Basel). 2023;15(6).","DOI":"10.3390\/cancers15061777"},{"issue":"3","key":"3749_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1470-2045(15)00553-7","volume":"17","author":"K Fujitani","year":"2016","unstructured":"Fujitani K, Yang HK, Mizusawa J, Kim YW, Terashima M, Han SU, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol. 2016;17(3):309\u201318.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3749_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29\u201342.","journal-title":"Ann Surg"},{"key":"3749_CR9","doi-asserted-by":"crossref","unstructured":"Boerner T, Piso P. Cytoreductive surgery for peritoneal carcinomatosis from gastric cancer: technical details. J Clin Med. 2021;10(22).","DOI":"10.3390\/jcm10225263"},{"issue":"3","key":"3749_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.currproblcancer.2009.06.003","volume":"33","author":"P Shen","year":"2009","unstructured":"Shen P, Stewart JHt, Levine EA. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: overview and rationale. Curr Probl Cancer. 2009;33(3):125\u201341.","journal-title":"Curr Probl Cancer"},{"issue":"12","key":"3749_CR11","doi-asserted-by":"publisher","first-page":"7244","DOI":"10.1245\/s10434-022-12383-6","volume":"29","author":"BD Badgwell","year":"2022","unstructured":"Badgwell BD. Don\u2019t call it a Comeback-HIPEC for gastric cancer. Ann Surg Oncol. 2022;29(12):7244\u20135.","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"3749_CR12","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","volume":"37","author":"PE Bonnot","year":"2019","unstructured":"Bonnot PE, Piessen G, Kepenekian V, Decullier E, Pocard M, Meunier B, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): A propensity score analysis. J Clin Oncol. 2019;37(23):2028\u201340.","journal-title":"J Clin Oncol"},{"issue":"7","key":"3749_CR13","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.ejso.2015.03.231","volume":"41","author":"F Coccolini","year":"2015","unstructured":"Coccolini F, Catena F, Glehen O, Yonemura Y, Sugarbaker PH, Piso P, et al. Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis. Eur J Surg Oncol. 2015;41(7):911\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"3749_CR14","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"XJ Yang","year":"2011","unstructured":"Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575\u201381.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3749_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jso.23633","volume":"110","author":"U Rudloff","year":"2014","unstructured":"Rudloff U, Langan RC, Mullinax JE, Beane JD, Steinberg SM, Beresnev T, et al. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol. 2014;110(3):275\u201384.","journal-title":"J Surg Oncol"},{"issue":"2","key":"3749_CR16","first-page":"295","volume":"29","author":"HJ Deng","year":"2009","unstructured":"Deng HJ, Wei ZG, Zhen L, Li GX, Uang XC, Qing SH. [Clinical application of perioperative continuous hyperthermic peritoneal perfusion chemotherapy for gastric cancer]. Nan Fang Yi Ke Da Xue Xue Bao. 2009;29(2):295\u20137.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"3749_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res"},{"key":"3749_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/CMAR.S343467","volume":"14","author":"Z Ye","year":"2022","unstructured":"Ye Z, Yu P, Cao Y, Chai T, Huang S, Cheng X, et al. Prediction of peritoneal cancer index and prognosis in peritoneal metastasis of gastric cancer using NLR-PLR-DDI score: A retrospective study. Cancer Manag Res. 2022;14:177\u201387.","journal-title":"Cancer Manag Res"},{"issue":"12","key":"3749_CR19","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1245\/s10434-010-1362-z","volume":"17","author":"K Washington","year":"2010","unstructured":"Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12):3077\u20139.","journal-title":"Ann Surg Oncol"},{"key":"3749_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2017.03.030","volume":"79","author":"J Desiderio","year":"2017","unstructured":"Desiderio J, Chao J, Melstrom L, Warner S, Tozzi F, Fong Y, et al. The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J Cancer. 2017;79:1\u201314.","journal-title":"Eur J Cancer"},{"issue":"8","key":"3749_CR21","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1097\/JS9.0000000000000457","volume":"109","author":"M Patel","year":"2023","unstructured":"Patel M, Arora A, Mukherjee D, Mukherjee S. Effect of hyperthermic intraperitoneal chemotherapy on survival and recurrence rates in advanced gastric cancer: a systematic review and meta-analysis. Int J Surg. 2023;109(8):2435\u201350.","journal-title":"Int J Surg"},{"key":"3749_CR22","doi-asserted-by":"crossref","unstructured":"Reutovich MY, Krasko OV, Sukonko OGJJGO. Hyperthermic intraperitoneal chemotherapy in prevention of gastric cancer metachronous peritoneal metastases: a systematic review. 2020:S5-S17.","DOI":"10.21037\/jgo-20-129"},{"issue":"12","key":"3749_CR23","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.ejso.2019.07.030","volume":"45","author":"MY Reutovich","year":"2019","unstructured":"Reutovich MY, Krasko OV, Sukonko OG. Hyperthermic intraperitoneal chemotherapy in serosa-invasive gastric cancer patients. Eur J Surg Oncol. 2019;45(12):2405\u201311.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"3749_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/1097-0142(19880115)61:2<232::AID-CNCR2820610205>3.0.CO;2-U","volume":"61","author":"S Koga","year":"1988","unstructured":"Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer. 1988;61(2):232\u20137.","journal-title":"Cancer"},{"key":"3749_CR25","first-page":"185092","volume":"2011","author":"K Van der Speeten","year":"2011","unstructured":"Van der Speeten K, Stuart OA, Mahteme H, Sugarbaker PH. Pharmacokinetic study of perioperative intravenous Ifosfamide. Int J Surg Oncol. 2011;2011:185092.","journal-title":"Int J Surg Oncol"},{"issue":"9","key":"3749_CR26","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1245\/s10434-007-9429-1","volume":"14","author":"S Kusamura","year":"2007","unstructured":"Kusamura S, Baratti D, Younan R, Laterza B, Oliva GD, Costanzo P, et al. Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity. Ann Surg Oncol. 2007;14(9):2550\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"3749_CR27","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/S1470-2045(16)30531-9","volume":"17","author":"SE Al-Batran","year":"2016","unstructured":"Al-Batran SE, Hofheinz RD, Pauligk C, Kopp HG, Haag GM, Luley KB, et al. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2\/3 trial. Lancet Oncol. 2016;17(12):1697\u2013708.","journal-title":"Lancet Oncol"},{"issue":"10184","key":"3749_CR28","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"SE Al-Batran","year":"2019","unstructured":"Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet. 2019;393(10184):1948\u201357.","journal-title":"Lancet"},{"issue":"9","key":"3749_CR29","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/jamaoncol.2017.0515","volume":"3","author":"SE Al-Batran","year":"2017","unstructured":"Al-Batran SE, Homann N, Pauligk C, Illerhaus G, Martens UM, Stoehlmacher J, et al. Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial. JAMA Oncol. 2017;3(9):1237\u201344.","journal-title":"JAMA Oncol"},{"key":"3749_CR30","doi-asserted-by":"crossref","unstructured":"Ramalho-Vasconcelos F, Gomes R, Bou\u00e7a-Machado R, Aral M, Nogueiro J, Bou\u00e7a-Machado T et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of gastric cancer: feasibility, efficacy and Safety-A systematic review and Meta-Analysis. J Clin Med. 2024;13(11).","DOI":"10.3390\/jcm13113320"},{"issue":"19","key":"3749_CR31","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1200\/JCO.2018.77.8613","volume":"36","author":"H Ishigami","year":"2018","unstructured":"Ishigami H, Fujiwara Y, Fukushima R, Nashimoto A, Yabusaki H, Imano M, et al. Phase III trial comparing intraperitoneal and intravenous Paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial. J Clin Oncol. 2018;36(19):1922\u20139.","journal-title":"J Clin Oncol"},{"issue":"40","key":"3749_CR32","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.3748\/wjg.v21.i40.11428","volume":"21","author":"S Pernot","year":"2015","unstructured":"Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge. World J Gastroenterol. 2015;21(40):11428\u201338.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"3749_CR33","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.ejso.2018.06.036","volume":"44","author":"C Rihuete Caro","year":"2018","unstructured":"Rihuete Caro C, Manzanedo I, Pereira F, Carrion-Alvarez L, Serrano \u00c1, P\u00e9rez-Viejo E. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis. Eur J Surg Oncol. 2018;44(11):1805\u201310.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"3749_CR34","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/curroncol31030109","volume":"31","author":"M Acs","year":"2024","unstructured":"Acs M, Piso P, Glockzin G. Peritoneal metastatic gastric cancer: local treatment options and recommendations. Curr Oncol. 2024;31(3):1445\u201359.","journal-title":"Curr Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03749-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03749-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03749-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T11:52:09Z","timestamp":1742385129000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03749-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3749"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03749-7","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was granted by the South Eastern Local Health District Ethics committee, under ethical approval code QAQI\/18\/078.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}